Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 187, Issue 1-2, 2001, Pages 27-34

  Ono, Seiitsu ^a   Hu, Jianguo ^b   Shimizu, Natsue ^a   Imai, Takashi ^c   Nakagawa, Hachiro ^b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BML   (Japan)

^c Chiba Nat Hosp   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Cytokine; Immunohistochemistry; Interleukin 6; Serum; Skin

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEGENERATIVE DISEASE; DERMIS; DISEASE DURATION; EPIDERMIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL DEGENERATION; PRIORITY JOURNAL; SKIN; SKIN BIOPSY; SKIN BLOOD VESSEL; TISSUE LEVEL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; SKIN;

EID: 0035875509     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00514-7     Document Type: Article

References (44)

1. Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin
2. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis
3. Amyotrophic lateral sclerosis: increased solubility of skin collagen
4. Alterations of skin glycosaminoglycans in patients with ALS
5. Ciliary neurotrophic factor in skin biopsies of patients with amyotrophic lateral sclerosis
6. Amyotrophic lateral sclerosis and bedsores
7. Prognosis of motor neuron disease in Japan
8. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis
9. 1b in patients with motor neuron disease without plasma cell dyscrasia
10. Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes
11. Cytokines: the fourth homeostatic system
12. Inhibiting the effects of cytokines in human diseases
13. The acute phase response of the liver in inflammation
14. Elevated levels of the 26 K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system
15. Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin
16. Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis
17. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis
18. Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6
19. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
20. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases
21. El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis
22. Functional evaluation: the Barthel index
23. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
24. Interleukin-6 serum concentrations in patients with multiple myeloma: bioassay versus enzyme-immunoassay
25. Interleukin-6 and the skin
26. IFN-β2, B cell differentiation factor 2, or hybridoma growth factor (IL6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines
27. Interleukin-6 in normal skin and psoriasis
28. Synthesis and secretion of multiple forms of β2-interferon B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes
29. Interleukin 6: insights to its function in skin by overexpression in transgenic mice
30. The production of TNF, IL-1 and IL-6 in cutaneous tissues during maturation and aging
31. Epidermal expression of interleukin-6 and tumor necrosis factor-alpha in normal and immunoinflammatory skin states in humans
32. Interleukin-6 and its relation to inflammation and disease
33. The association of plasma IL-6 levels with functional disability in community-dwelling elderly
34. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis
35. The role of interleukin-6 in certain age-related diseases
36. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis
37. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders
38. Increased serum interleukin 6 levels in patients with myelodysplastic syndromes
39. Correlated increases of tumor necrosis factor-α, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity
40. Evaluation of IL-2, sIL2R, IL-6, THF-α, and IL-1β levels in serum and CSF of patients with optic neuritis
41. Interleukin-6 is elevated in plasma in multiple sclerosis
42. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats
43. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production
44. Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid